Bio-Rad Laboratories, Inc. (BIO)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 304.92 |
| Open | 305.00 |
| Bid | 239.12 x 800 |
| Ask | 336.67 x 800 |
| Day's range | 300.98 - 308.27 |
| 52-week range | 261.59 - 509.62 |
| Volume | |
| Avg. volume | 250,960 |
| Market cap | 8.947B |
| Beta (5Y monthly) | 0.91 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.02 |
| Earnings date | 14 Feb 2024 - 19 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 426.40 |
ZacksImplied Volatility Surging for On Bio-Rad Laboratories (BIO) Stock Options
Investors need to pay close attention to Bio-Rad Laboratories (BIO) stock based on the movements in the options market lately.
ZacksBio-Rad (BIO) Hurt by Macroeconomic Woes, Margin Pressure
Bio-Rad's (BIO) margin performance is affected by the inflationary trend of elevated raw material costs, increased logistics costs and higher employee-related expenses.
ZacksBio-Rad (BIO) Misses Q3 Earnings Estimates, Cuts 2023 View
The deterioration in biopharma and early biotech customer spending and a challenging macroeconomic environment in China impact Bio-Rad's (BIO) Q3 performance.
© 2023 Yahoo. All rights reserved.